Comparison of percutaneous absorption and metabolism of di-n-butylphthalate in various species

Toxicology in Vitro

Volumn 24, Issue 1, 2010, Pages 71-78

  Beydon, Dominique ^a   Payan, Jean Paul ^a   Grandclaude, Marie Christine ^a  

^a INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

Author keywords

Animal species; Di n butylphthalate; Esterase activity; Ex vivo; Human; Percutaneous absorption; Skin

Indexed keywords

CARBOXYLESTERASE; ESTERASE; PHTHALIC ACID DIBUTYL ESTER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMIS; ENZYME ACTIVITY; EPIDERMIS; EX VIVO STUDY; EXPERIMENTAL MODEL; GUINEA PIG; HAIRLESS MOUSE; HAIRLESS RAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; MOUSE; NONHUMAN; PREDICTION; RABBIT; RAT; SKIN ABSORPTION; SKIN PENETRATION; SPECIES DIFFERENCE; TOXICOKINETICS;

ANIMALS; BIOTRANSFORMATION; CARBOXYLIC ESTER HYDROLASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DERMIS; DIBUTYL PHTHALATE; DIFFUSION CHAMBERS, CULTURE; ENZYME INHIBITORS; EPIDERMIS; ESTERASES; GUINEA PIGS; HUMANS; MICE; MICE, HAIRLESS; PLASTICIZERS; RABBITS; RATS; RATS, HAIRLESS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION; SPECIES SPECIFICITY;

ANIMALIA; CAVIA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 72049101462     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.08.032     Document Type: Article

References (31)

1. Ahmed S., Imai T., and Otagiri M. Stereoselective hydrolysis and penetration of propranolol prodrugs: in vitro evaluation using hairless mouse skin. J. Pharm. Sci. 84 (1995) 877-883
2. Ahmed S., Imai T., Yoshigae Y., and Otagiri M. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma. Life Sci. 61 (1997) 1887
3. Bando H., Mohri S., Yamashita F., Akakura Y., and Hashida M. Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J. Pharm. Sci. 86 (1997) 759-761
4. Barbero A.M., and Frasch H.F. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol. in Vitro 23 (2009) 1-13
5. Boehnlein J., Sakr A., Lichtin J.L., and Bronaugh R.L. Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption. Pharm. Res. 11 (1994) 1155-1159
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 254
7. Godin B., and Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv. Drug Delivery Rev. 59 (2007) 1152-1161
8. Hewitt P.G., Perkins J., and Hotchkiss S.A. Metabolism of fluroxypyr, fluroxypyr methyl ester, and the herbicide fluroxypyr methylheptyl ester. I: during percutaneous absorption through fresh rat and human skin in vitro. Drug Metab. Dispos. 28 (2000) 748-754
9. Hewitt P.G., Perkins J., and Hotchkiss S.A. Metabolism of fluroxypyr, fluroxypyr methyl ester, and the herbicide fluroxypyr methylheptyl ester. II: in rat skin homogenates. Drug Metab. Dispos. 28 (2000) 755-759
10. Heymann E., Hoppe W., Krusselmann A., and Tschoetschel C. Organophosphate sensitive and insensitive carboxylesterases in human skin. Chem.-Biol. Interact. 87 (1993) 226
11. Jewell C., Ackermann C., Payne N.A., Fate G., Voorman R., and Williams F.M. Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver. Drug Metab. Dispos. 35 (2007) 2015-2022
12. Jewell C., Prusakiewicz J.J., Ackermann C., Payne N.A., Fate G., and Williams F.M. The distribution of esterases in the skin of the minipig. Toxicol. Lett. 173 (2007) 123
13. McCracken N.W., Blain P.G., and Williams F.M. Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem. Pharmacol. 45 (1993) 36
14. Muller B., Kasper M., Surber C., and Imanidis G. Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin: correlation with topical pharmacological effect. Eur. J. Pharm. Sci. 20 (2003) 195
15. Nangia A., Patil S., Berner B., Boman A., and Maibach H. In vitro measurement of transepidermal water loss: a rapid alternative to tritiated water permeation for assessing skin barrier functions. Int. J. Pharm. 170 (1998) 40
16. Ngawhirunpat T., Opanasopit P., and Prakongpan S. Comparison of skin transport and metabolism of ethyl nicotinate in various species. Eur. J. Pharm. Biopharm. 58 (2004) 651
17. OECD, 2004. Test Guideline 428: Skin absorption: in vitro Method. Organization for Economic and Cooperation and Development, Paris, France.
18. Payan J.P., Marty J.P., Fabry J.P., Beydon D., Boudry I., Ferrari E., Canel F., Grandclaude M.C., and Vincent C.M. In vivo and in vitro percutaneous absorption of [(14)C]di-N-butylphthalate in rat. Drug Metab. Dispos. 29 (2001) 843-854
19. Poet T.S., and McDougal J.N. Skin absorption and human risk assessment. Chem.-Biol. Interact. 140 (2002) 19-34
20. Prusakiewicz J.J., Ackermann C., and Voorman R. Comparison of skin esterase activities from different species. Pharm. Res. 23 (2006) 1517-1524
21. Saillenfait A.M., Payan J.P., Fabry J.P., Beydon D., Langonne I., Gallissot F., and Sabate J.P. Assessment of the developmental toxicity, metabolism, and placental transfer of di-n-butyl phthalate administered to pregnant rats. Toxicol. Sci. 45 (1998) 212-224
22. Satoh T., and Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 257-288
23. Scott R.C., Dugard P.H., and Ramsey J.D. In vitro absorption of some o-phthalate diesters through human and rat skin. Environ. Health Perspect. 74 (1987) 223-227
24. Seko N., Bando H., Lim C.W., Yamashita F., and Hashida M. Theoretical analysis of the effect of cutaneous metabolism on skin permeation of parabens based on a two-layer skin diffusion/metabolism model. Biol. Pharm. Bull. 22 (1999) 281-287
25. Steinstrasser I., and Merkle H.P. Dermal metabolism of topically applied drugs: pathways and models reconsidered. Pharm. Acta Helv. 70 (1995) 24
26. Täuber, U., Rost, K.L., 1987. Esterase activity of the skin including species variations. In: Skin Pharmacology, vol. 1, Karger, Basel, pp. 170-183.
27. Williams E.T., Ehsani M.E., Wang X., Wang H., Qian Y.-W., Wrighton S.A., and Perkins E.J. Effect of buffer components and carrier solvents on in vitro activity of recombinant human carboxylesterases. J. Pharm. Toxicol. Methods 57 (2008) 138-144
28. Williams F.M. In vitro studies - how good are they at replacing in vivo studies for measurement of skin absorption?. Environ. Toxicol. Pharmacol. 21 (2006) 199-203
29. Winkelmann R., and Schmit R.W. Cholinesterase in the Skin of the Rat, Dog, Cat, Guinea Pig and Rabbit1. J. Invest. Dermatol. 33 (1959) 185-190
30. Zhang J.-G., and Fariss M.W. Thenoyltrifluoroacetone, a potent inhibitor of carboxylesterase activity. Biochem. Pharmacol. 63 (2002) 754
31. Zhu Q.G., Hu J.H., and Zeng H.W. Stereoselectivity of skin carboxylesterase metabolism. Yao Xue Xue Bao 40 (2005) 322-326